Achillion Pharmaceuticals Inc. (ACHN)

3.77
0.03 0.67
NASDAQ : Health Technology
Prev Close 3.74
Open 3.71
Day Low/High 3.71 / 3.83
52 Wk Low/High 1.29 / 5.03
Volume 180.63K
Avg Volume 1.51M
Exchange NASDAQ
Shares Outstanding 139.69M
Market Cap 528.04M
EPS -0.50
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Achillion Reports Second Quarter 2019 Financial Results And Provides Corporate Update

Achillion Reports Second Quarter 2019 Financial Results And Provides Corporate Update

- Danicopan (ACH-4471) Phase 2 combination therapy interim data showed clinically meaningful improvements in laboratory parameters of PNH; End-of-Phase 2 meeting activities initiated with FDA - - ACH-5228's near complete and sustained inhibition of the...

Notable Tuesday Option Activity: ACHN, AMCX, MSFT

Notable Tuesday Option Activity: ACHN, AMCX, MSFT

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Achillion Pharmaceuticals Inc , where a total volume of 5,500 contracts has been traded thus far today, a contract volume which is representative of approximately 550,000 underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 67.4% of ACHN's average daily trading volume over the past month, of 815,425 shares.

Interesting ACHN Put And Call Options For March 2020

Interesting ACHN Put And Call Options For March 2020

Investors in Achillion Pharmaceuticals Inc saw new options begin trading this week, for the March 2020 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 241 days until expiration the newly trading contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Achillion's ACH-5228 Achieves Positive Results In Phase 1 Multiple Ascending Dose Study In Healthy Volunteers

Achillion's ACH-5228 Achieves Positive Results In Phase 1 Multiple Ascending Dose Study In Healthy Volunteers

ACH-5228 delivers near complete and sustained inhibition of the complement alternative pathway Twice-daily oral administration to move forward in Phase 2 trials Investigational New Drug (IND) application to be submitted in fourth quarter of 2019 BLUE...

Interesting ACHN Call Options For August 16th

Interesting ACHN Call Options For August 16th

Investors in Achillion Pharmaceuticals Inc saw new options become available this week, for the August 16th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ACHN options chain for the new August 16th contracts and identified the following call contract of particular interest.

Interesting ACHN Call Options For July 19th

Interesting ACHN Call Options For July 19th

Investors in Achillion Pharmaceuticals Inc saw new options begin trading this week, for the July 19th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ACHN options chain for the new July 19th contracts and identified the following call contract of particular interest.

Biotech and Beyond: 8 Favorite Healthcare Stocks for 2019

Biotech and Beyond: 8 Favorite Healthcare Stocks for 2019

From small-cap genetics and biotech firms to large-cap drug distributors and pharmacies, eight experts select their top picks in the space for this year.

First Week Of February 15th Options Trading For Achillion Pharmaceuticals (ACHN)

First Week Of February 15th Options Trading For Achillion Pharmaceuticals (ACHN)

Investors in Achillion Pharmaceuticals Inc saw new options become available this week, for the February 15th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ACHN options chain for the new February 15th contracts and identified the following call contract of particular interest.

First Week Of June 2019 Options Trading For Achillion Pharmaceuticals (ACHN)

First Week Of June 2019 Options Trading For Achillion Pharmaceuticals (ACHN)

Investors in Achillion Pharmaceuticals Inc saw new options become available this week, for the June 2019 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 239 days until expiration the newly available contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Interesting ACHN Put And Call Options For March 2019

Interesting ACHN Put And Call Options For March 2019

Investors in Achillion Pharmaceuticals Inc saw new options begin trading this week, for the March 2019 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 233 days until expiration the newly trading contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

First Week Of ACHN August 17th Options Trading

First Week Of ACHN August 17th Options Trading

Investors in Achillion Pharmaceuticals Inc saw new options begin trading this week, for the August 17th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ACHN options chain for the new August 17th contracts and identified the following call contract of particular interest.

First Week of ACHN September 21st Options Trading

First Week of ACHN September 21st Options Trading

Investors in Achillion Pharmaceuticals Inc saw new options begin trading this week, for the September 21st expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 239 days until expiration the newly trading contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

First Week Of February 2018 Options Trading For Achillion Pharmaceuticals (ACHN)

First Week Of February 2018 Options Trading For Achillion Pharmaceuticals (ACHN)

Investors in Achillion Pharmaceuticals Inc saw new options become available this week, for the February 2018 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ACHN options chain for the new February 2018 contracts and identified the following call contract of particular interest.

Short Interest Moves 18.3% Lower For ACHN

Short Interest Moves 18.3% Lower For ACHN

The most recent short interest data has been released for the 11/30/2017 settlement date, which shows a 1,585,169 share decrease in total short interest for Achillion Pharmaceuticals Inc. , to 7,056,852, a decrease of 18.34% since 11/15/2017.

First Week of June 2018 Options Trading For Achillion Pharmaceuticals (ACHN)

First Week of June 2018 Options Trading For Achillion Pharmaceuticals (ACHN)

Investors in Achillion Pharmaceuticals Inc. saw new options become available this week, for the June 2018 expiration.

Achillion Reports Third Quarter 2017 Financial Results And Provides Update On Clinical Programs

Achillion Reports Third Quarter 2017 Financial Results And Provides Update On Clinical Programs

Robust balance sheet to support global expansion of ACH-4471 clinical development program in PNH and C3G